Morena Fasano

SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer

Carminia Maria Della Corte, Claudio Bellevicine, Giovanni Vicidomini et al. · Clinical Cancer Research · 2015 · 116 citations · Full text

Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I–II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer

Floriana Morgillo, Morena Fasano, Carminia Maria Della Corte et al. · ESMO Open · 2017 · 74 citations · Full text

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells

Carminia Maria Della Corte, Vincenza Ciaramella, Concetta Di Mauro et al. · Oncotarget · 2015 · 68 citations · Full text

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study

Luca Rinaldi, Alessandro Perrella, Maria Guarino et al. · Journal of Translational Medicine · 2019 · 61 citations · Full text

Gut microbiota correlates with antitumor activity in patients with <scp>mCRC</scp> and <scp>NSCLC</scp> treated with cetuximab plus avelumab

Giulia Martini, Davide Ciardiello, Marcello Dallio et al. · International Journal of Cancer · 2022 · 61 citations · Full text

Dysbiosis, Antitumor Activity, Immunology +17